Here are what the editors at HealthDay consider to be the most important developments in Urology for August 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Delayed Radiotherapy Not Tied to Worse Survival in Prostate Cancer
FRIDAY, Aug. 14, 2020 (HealthDay News) — For men with prostate cancer (PC), initiation of radiotherapy (RT) up to six months after androgen deprivation therapy (ADT) is not associated with worse overall survival (OS), according to a research letter published online Aug. 13 in JAMA Oncology.
Patient-Reported Outcome Measure May Be Useful in Hemodialysis
WEDNESDAY, Aug. 26, 2020 (HealthDay News) — A patient-reported outcome measure (PROM) can standardize symptom screening processes and improve symptom awareness for hemodialysis patients in routine clinical care, according to a study published online Aug. 25 in the Clinical Journal of the American Society of Nephrology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Advisory Panel Rejects Nearly All Proposals for Fetal Tissue Research
THURSDAY, Aug. 20, 2020 (HealthDay News) — A Trump administration advisory board to evaluate scientific research involving fetal tissue says 13 of 14 proposals should be rejected.
Poll: More Older Adults Using Telehealth During Pandemic
WEDNESDAY, Aug. 19, 2020 (HealthDay News) — More older adults have used telehealth to consult with a health care provider during the COVID-19 pandemic compared with that seen in the previous year, according to a report published online Aug. 17 based on the results of the University of Michigan National Poll on Healthy Aging.
Guidance Issued for Genetic Testing in Prostate Cancer
MONDAY, Aug. 17, 2020 (HealthDay News) — As a result of the Philadelphia Prostate Cancer Consensus Conference, hosted by Sidney Kimmel Cancer Center-Jefferson Health and the Department of Urology at Jefferson, recommendations have been developed for implementing germline testing for prostate cancer. The consensus framework was recently published in the Journal of Clinical Oncology.
Return-to-School Recommendations Issued for Organ Transplant Recipients
FRIDAY, Aug. 14, 2020 (HealthDay News) — For solid organ transplant (SOT) recipients, the decision of whether to return to school should be a shared decision between families, transplant professionals, and educators, according to an expert opinion article published online Aug. 4 in the Journal of the Pediatric Infectious Diseases Society.
Abstract/Full Text (subscription or payment may be required)
Burnout Less Likely for Doctors in Minority Race/Ethnic Groups
.jpg)
Tadalafil Linked to Glaucoma in Men With Lower Urinary Tract Symptoms 
Platelet-Rich Plasma, Shockwave Therapy Show Therapeutic Efficacy in Interstitial Cystitis 
About One-Third of Men Continuously Using Tamsulosin See Minimal to No Effect 
Remote Access to Urinary Incontinence Treatments Aids Women Veterans 
App Can Help Reduce Interdialytic Weight Gain in Chronic Hemodialysis 
Organized Sports-Based Interventions Can Improve Gross Motor Skills in Autism 
Smartphone-Based Self-Screening Can ID Ocular Surface Malignancies 
Smartphone Apps, Wearables Boost Activity in People With Cardiovascular Disease 
